The multidimensional measurement of the positive symptoms of psychosis

被引:48
作者
Steel, Craig
Garety, Philippa A.
Freeman, Daniel
Craig, Ellen
Kuipers, Elizabeth
Bebbington, Paul
Fowler, David
Dunn, Graham
机构
[1] Inst Psychiat, Dept Psychol, London SE5 8AF, England
[2] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England
[3] Univ Manchester, Manchester, Lancs, England
[4] UCL, Dept Mental Hlth Sci, London, England
基金
英国惠康基金;
关键词
PSYRATS; multidimensional; psychosis; symptoms; measurement;
D O I
10.1002/mpr.203
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The measures most frequently used to assess psychotic symptoms fail to reflect important dimensions. The Psychotic Symptom Rating Scale (PSYRATS) aims to capture the multidimensional nature of auditory hallucinations and delusions. Individuals (N = 276) who had recently relapsed with positive symptoms completed the auditory hallucinations and delusions PSYRATS scales. These scores were compared with the relevant items from the SAPS and PANSS, and with measures of current mood. Total scores and distribution of items of the PSYRATS scales are presented and correlated with other measures. Positive symptom items from the SAPS and PANSS reflected the more objective aspects of PSYRATS ratings of auditory hallucinations and delusions (frequency and conviction) but were relatively poor at measuring distress. A major strength of the PSYRATS scales is the specific measurement of the distress dimension of symptoms, which is a key target of psychological intervention. It is advised that the PSYRATS should not be used as a total score alone, whilst further research is needed to clarify the best use of potential subscales. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 50 条
  • [41] Thalamocortical connectivity and its relationship with symptoms and cognition across the psychosis continuum
    Ramsay, Ian S.
    Mueller, Bryon
    Ma, Yizhou
    Shen, Chen
    Sponheim, Scott R.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (12) : 5582 - 5591
  • [42] Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients
    Brucato, Gary
    First, Michael B.
    Dishy, Gabriella A.
    Samuel, Shana S.
    Xu, Qing
    Wall, Melanie M.
    Small, Scott A.
    Masucci, Michael D.
    Lieberman, Jeffrey A.
    Girgis, Ragy R.
    PSYCHOLOGICAL MEDICINE, 2021, 51 (01) : 112 - 120
  • [43] Comprehensive review of multidimensional biomarkers in the ShangHai At Risk for Psychosis (SHARP) program for early psychosis identification
    Zhang, TianHong
    Xu, LiHua
    Tang, XiaoChen
    Wei, YanYan
    Hu, YeGang
    Cui, HuiRu
    Tang, YingYing
    Li, ChunBo
    Wang, JiJun
    PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS, 2023, 2 (04):
  • [44] Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms
    Gerstenberg, M.
    Theodoridou, A.
    Traber-Walker, N.
    Franscini, M.
    Wotruba, D.
    Metzler, S.
    Mueller, M.
    Dvorsky, D.
    Correll, C. U.
    Walitza, S.
    Roessler, W.
    Heekeren, K.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (05) : 1069 - 1078
  • [45] Are family warmth and positive remarks related to outcomes in psychosis? A systematic review
    Butler, Rebecca
    Berry, Katherine
    Varese, Filippo
    Bucci, Sandra
    PSYCHOLOGICAL MEDICINE, 2019, 49 (08) : 1250 - 1265
  • [46] MULTIDIMENSIONAL FACTOR STRUCTURE OF POSITIVE SCHIZOTYPY
    Cicero, David C.
    Kerns, John G.
    JOURNAL OF PERSONALITY DISORDERS, 2010, 24 (03) : 327 - 343
  • [47] Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome
    Carrion, Ricardo E.
    Demmin, Docia
    Auther, Andrea M.
    McLaughlin, Danielle
    Olsen, Ruth
    Lencz, Todd
    Correll, Christoph U.
    Cornblatt, Barbara A.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 81 : 95 - 101
  • [48] From predisposition to psychosis: progression of symptoms in schizophrenia
    Parnas, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1999, 99 : 20 - 29
  • [49] The structure of psychosis revisited: The role of mood symptoms
    Boks, Marco P. M.
    Leask, Stuart
    Vermunt, Jeroen K.
    Kahn, Rene S.
    SCHIZOPHRENIA RESEARCH, 2007, 93 (1-3) : 178 - 185
  • [50] NEW PHARMACOTHERAPEUTIC MODALITIES FOR NEGATIVE SYMPTOMS IN PSYCHOSIS
    LINDENMAYER, JP
    ACTA PSYCHIATRICA SCANDINAVICA, 1995, 91 : 15 - 19